Exploring the role of chondroitin sulfate in brain health and disease

Chemical approaches to understanding chondroitin sulfate glycosaminoglycans and their roles in brain plasticity and pathology

NIH-funded research California Institute of Technology · NIH-11105859

This study is looking at special molecules in the brain called chondroitin sulfate glycosaminoglycans (CS GAGs) to see how their different structures can help with memory and healing, which could lead to better treatments for conditions like Alzheimer's disease and help the brain recover from injuries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology NIH-funded
Lab location1 site (Pasadena, United States)
Project IDNIH-11105859 on NIH RePORTER

What this research studies

This research investigates chondroitin sulfate glycosaminoglycans (CS GAGs), which are important molecules in the brain that influence development, immunity, and recovery from injuries. The project aims to understand how different chemical structures of CS GAGs affect brain functions such as memory and healing. By using advanced chemical techniques, researchers will identify specific roles of these molecules in brain plasticity and neuroinflammation, potentially leading to new treatments for conditions like Alzheimer's disease. Patients may benefit from insights that could improve therapies for neurodegenerative diseases and enhance brain repair mechanisms.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with neurodegenerative conditions such as Alzheimer's disease, as well as younger patients experiencing brain injuries.

Not a fit: Patients with non-neurological conditions or those not affected by brain plasticity issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for enhancing brain repair and treating neurodegenerative diseases.

How similar studies have performed: Previous research has shown promising results in understanding the roles of glycosaminoglycans in brain function, suggesting that this approach could yield valuable insights.

Where this research is happening

Pasadena, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.